Articles

Export this record

Export selected records

Export record to excel

File type to download

Beta version

Record title

P142 ROS101, a novel targeted methotrexate prodrug, selectively activated by reactive oxygen species (ROS) shows reduced toxicity in rat CIA model of rheumatoid arthritis

Record identifier

TN_cdi_proquest_journals_2186661053

P142 ROS101, a novel targeted methotrexate prodrug, selectively activated by reactive oxygen species (ROS) shows reduced toxicity in rat CIA model of rheumatoid arthritis

ACCESS
https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2186661053

P142 ROS101, a novel targeted methotrexate prodrug, selectively activated by reactive oxygen species (ROS) shows reduced toxicity in rat CIA model of rheumatoid arthritis

Full title

P142 ROS101, a novel targeted methotrexate prodrug, selectively activated by reactive oxygen species (ROS) shows reduced toxicity in rat CIA model of rheumatoid arthritis

Publisher

London: BMJ Publishing Group LTD

Journal title

Annals of the rheumatic diseases, 2019, Vol.78 (Suppl 1), p.A62

Record Identifier

TN_cdi_proquest_journals_2186661053

Language

English

Formats

Publication information

Publisher

More information

SCOPE AND CONTENTS

Contents

ALTERNATIVE TITLES

Full title

Identifiers

PRIMARY IDENTIFIERS

Record Identifier

TN_cdi_proquest_journals_2186661053

Permalink

https://collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_2186661053

OTHER IDENTIFIERS

ISSN

E-ISSN

DOI

How to access this item

Online

1 item

How to access?

Login with a Library card